{"id":8351,"date":"2019-06-25T14:11:31","date_gmt":"2019-06-25T18:11:31","guid":{"rendered":"https:\/\/www.silverlaw.com\/blog\/?p=8351"},"modified":"2019-06-25T14:11:31","modified_gmt":"2019-06-25T18:11:31","slug":"intersect-ent-inc-xent-subject-of-a-class-action-lawsuit","status":"publish","type":"post","link":"https:\/\/www.silverlaw.com\/blog\/intersect-ent-inc-xent-subject-of-a-class-action-lawsuit\/","title":{"rendered":"Intersect ENT, Inc. (XENT) Subject Of A Class Action Lawsuit"},"content":{"rendered":"<p><img loading=\"lazy\" decoding=\"async\" class=\"alignleft size-medium wp-image-8353\" src=\"https:\/\/www.silverlaw.com\/blog\/wp-content\/uploads\/2019\/06\/stethoscope2-300x200.jpg\" alt=\"Intersect ENT, Inc. (XENT), a publicly-traded company that makes medical implants, is the subject of a class action lawsuit filed on behalf of shareholders who lost money investing in the company. Investors who purchased shares of Intersect between August 1, 2018 and May 6, 2019 (the class period) may be eligible to participate in the lawsuit, which concerns violations of federal securities laws.\" width=\"300\" height=\"200\" srcset=\"https:\/\/www.silverlaw.com\/blog\/wp-content\/uploads\/2019\/06\/stethoscope2.jpg 300w, https:\/\/www.silverlaw.com\/blog\/wp-content\/uploads\/2019\/06\/stethoscope2-180x120.jpg 180w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/>Intersect ENT, Inc. (XENT), a publicly-traded company that makes medical implants, is the subject of a class action lawsuit filed on behalf of shareholders who lost money investing in the company.<\/p>\n<h3>Intersect Class Period And Lead Plaintiff Deadline<\/h3>\n<p>Investors who purchased shares of Intersect between August 1, 2018 and May 6, 2019 (the class period) may be eligible to participate in the lawsuit, which concerns violations of federal securities laws. <a href=\"https:\/\/www.silverlaw.com\/blog\/intersect-ent-inc-xent-subject-of-a-class-action-lawsuit\/#more-8351\" class=\"more-link\">Continue reading \u203a<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Intersect ENT, Inc. (XENT), a publicly-traded company that makes medical implants, is the subject of a class action lawsuit filed on behalf of shareholders who lost money investing in the company. Investors who purchased shares of Intersect between August 1, 2018 and May 6, 2019 (the class period) may be eligible to participate in the lawsuit, which concerns violations of federal securities laws.<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[602,1646],"tags":[],"class_list":["post-8351","post","type-post","status-publish","format-standard","hentry","category-class-action","category-securities-fraud"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v25.7 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Intersect ENT, Inc. (XENT) Subject Of A Class Action Lawsuit<\/title>\n<meta name=\"description\" content=\"Intersect ENT, Inc. (XENT), a publicly-traded company that makes medical implants, is the subject of a class action lawsuit filed on behalf of shareholders.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.silverlaw.com\/blog\/intersect-ent-inc-xent-subject-of-a-class-action-lawsuit\/\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"Intersect ENT, Inc. (XENT) Subject Of A Class Action Lawsuit\" \/>\n<meta name=\"twitter:description\" content=\"Intersect ENT, Inc. (XENT), a publicly-traded company that makes medical implants, is the subject of a class action lawsuit filed on behalf of shareholders.\" \/>\n<meta name=\"twitter:image\" content=\"https:\/\/www.silverlaw.com\/blog\/wp-content\/uploads\/2019\/06\/stethoscope2.jpg\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Silver Law Group\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Intersect ENT, Inc. (XENT) Subject Of A Class Action Lawsuit","description":"Intersect ENT, Inc. (XENT), a publicly-traded company that makes medical implants, is the subject of a class action lawsuit filed on behalf of shareholders.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.silverlaw.com\/blog\/intersect-ent-inc-xent-subject-of-a-class-action-lawsuit\/","twitter_card":"summary_large_image","twitter_title":"Intersect ENT, Inc. (XENT) Subject Of A Class Action Lawsuit","twitter_description":"Intersect ENT, Inc. (XENT), a publicly-traded company that makes medical implants, is the subject of a class action lawsuit filed on behalf of shareholders.","twitter_image":"https:\/\/www.silverlaw.com\/blog\/wp-content\/uploads\/2019\/06\/stethoscope2.jpg","twitter_misc":{"Written by":"Silver Law Group","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.silverlaw.com\/blog\/intersect-ent-inc-xent-subject-of-a-class-action-lawsuit\/","url":"https:\/\/www.silverlaw.com\/blog\/intersect-ent-inc-xent-subject-of-a-class-action-lawsuit\/","name":"Intersect ENT, Inc. (XENT) Subject Of A Class Action Lawsuit","isPartOf":{"@id":"https:\/\/www.silverlaw.com\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.silverlaw.com\/blog\/intersect-ent-inc-xent-subject-of-a-class-action-lawsuit\/#primaryimage"},"image":{"@id":"https:\/\/www.silverlaw.com\/blog\/intersect-ent-inc-xent-subject-of-a-class-action-lawsuit\/#primaryimage"},"thumbnailUrl":"https:\/\/www.silverlaw.com\/blog\/wp-content\/uploads\/2019\/06\/stethoscope2-300x200.jpg","datePublished":"2019-06-25T18:11:31+00:00","author":{"@id":"https:\/\/www.silverlaw.com\/blog\/#\/schema\/person\/de64d999508b1ad10d608a99f0d2e752"},"description":"Intersect ENT, Inc. (XENT), a publicly-traded company that makes medical implants, is the subject of a class action lawsuit filed on behalf of shareholders.","breadcrumb":{"@id":"https:\/\/www.silverlaw.com\/blog\/intersect-ent-inc-xent-subject-of-a-class-action-lawsuit\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.silverlaw.com\/blog\/intersect-ent-inc-xent-subject-of-a-class-action-lawsuit\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.silverlaw.com\/blog\/intersect-ent-inc-xent-subject-of-a-class-action-lawsuit\/#primaryimage","url":"https:\/\/www.silverlaw.com\/blog\/wp-content\/uploads\/2019\/06\/stethoscope2.jpg","contentUrl":"https:\/\/www.silverlaw.com\/blog\/wp-content\/uploads\/2019\/06\/stethoscope2.jpg","width":300,"height":200,"caption":"Intersect ENT, Inc. (XENT), a publicly-traded company that makes medical implants, is the subject of a class action lawsuit filed on behalf of shareholders who lost money investing in the company. Investors who purchased shares of Intersect between August 1, 2018 and May 6, 2019 (the class period) may be eligible to participate in the lawsuit, which concerns violations of federal securities laws."},{"@type":"BreadcrumbList","@id":"https:\/\/www.silverlaw.com\/blog\/intersect-ent-inc-xent-subject-of-a-class-action-lawsuit\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.silverlaw.com\/blog\/"},{"@type":"ListItem","position":2,"name":"Intersect ENT, Inc. (XENT) Subject Of A Class Action Lawsuit"}]},{"@type":"WebSite","@id":"https:\/\/www.silverlaw.com\/blog\/#website","url":"https:\/\/www.silverlaw.com\/blog\/","name":"Securities Arbitration Lawyers Blog","description":"Published by Securities Arbitration Lawyers \u2014 Silver Law Group","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.silverlaw.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.silverlaw.com\/blog\/#\/schema\/person\/de64d999508b1ad10d608a99f0d2e752","name":"Silver Law Group","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.silverlaw.com\/blog\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/9eb0a691642ae95c68ee1c45b5f50f35bae76a41f3d9f861c7bfd40c87661746?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/9eb0a691642ae95c68ee1c45b5f50f35bae76a41f3d9f861c7bfd40c87661746?s=96&d=mm&r=g","caption":"Silver Law Group"}}]}},"jetpack_featured_media_url":"","_links":{"self":[{"href":"https:\/\/www.silverlaw.com\/blog\/wp-json\/wp\/v2\/posts\/8351","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.silverlaw.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.silverlaw.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.silverlaw.com\/blog\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.silverlaw.com\/blog\/wp-json\/wp\/v2\/comments?post=8351"}],"version-history":[{"count":2,"href":"https:\/\/www.silverlaw.com\/blog\/wp-json\/wp\/v2\/posts\/8351\/revisions"}],"predecessor-version":[{"id":8354,"href":"https:\/\/www.silverlaw.com\/blog\/wp-json\/wp\/v2\/posts\/8351\/revisions\/8354"}],"wp:attachment":[{"href":"https:\/\/www.silverlaw.com\/blog\/wp-json\/wp\/v2\/media?parent=8351"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.silverlaw.com\/blog\/wp-json\/wp\/v2\/categories?post=8351"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.silverlaw.com\/blog\/wp-json\/wp\/v2\/tags?post=8351"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}